SYRS Annual Net Income
-$164.57 M
-$69.92 M-73.87%
31 December 2023
Summary:
As of January 23, 2025, SYRS annual net profit is -$164.57 million, with the most recent change of -$69.92 million (-73.87%) on December 31, 2023. During the last 3 years, it has fallen by -$80.54 million (-95.83%). SYRS annual net income is now -1125.33% below its all-time high of -$13.43 million, reached on December 31, 2014.SYRS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRS Quarterly Net Income
-$6.40 M
+$16.93 M+72.58%
30 September 2024
Summary:
As of January 23, 2025, SYRS quarterly net profit is -$6.40 million, with the most recent change of +$16.93 million (+72.58%) on September 30, 2024. Over the past year, it has increased by +$33.75 million (+84.07%). SYRS quarterly net income is now -72.49% below its all-time high of -$3.71 million, reached on March 31, 2024.SYRS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRS TTM Net Income
-$97.81 M
+$33.75 M+25.65%
30 September 2024
Summary:
As of January 23, 2025, SYRS TTM net profit is -$97.81 million, with the most recent change of +$33.75 million (+25.65%) on September 30, 2024. Over the past year, it has increased by +$7.15 million (+6.81%). SYRS TTM net income is now -2041.31% below its all-time high of -$4.57 million, reached on March 31, 2015.SYRS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRS Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -73.9% | +84.1% | +6.8% |
| 3 y3 years | -95.8% | +73.1% | -4.8% |
| 5 y5 years | -164.3% | +73.1% | -4.8% |
SYRS Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -90.1% | at low | -72.5% | +90.1% | -13.0% | +40.6% |
| 5 y | 5-year | -118.2% | at low | -72.5% | +90.1% | -32.8% | +40.6% |
| alltime | all time | -1125.3% | at low | -72.5% | +90.1% | -2041.3% | +40.6% |
Syros Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$6.40 M(-72.6%) | -$97.81 M(-25.7%) |
| June 2024 | - | -$23.33 M(+529.1%) | -$131.56 M(-8.9%) |
| Mar 2024 | - | -$3.71 M(-94.2%) | -$144.49 M(-12.2%) |
| Dec 2023 | -$164.57 M(+73.9%) | -$64.38 M(+60.4%) | -$164.57 M(+56.8%) |
| Sept 2023 | - | -$40.14 M(+10.7%) | -$104.96 M(+10.4%) |
| June 2023 | - | -$36.26 M(+52.4%) | -$95.07 M(+1.9%) |
| Mar 2023 | - | -$23.79 M(+398.3%) | -$93.30 M(-1.4%) |
| Dec 2022 | -$94.65 M(+9.4%) | -$4.77 M(-84.2%) | -$94.65 M(-16.7%) |
| Sept 2022 | - | -$30.25 M(-12.3%) | -$113.69 M(+3.9%) |
| June 2022 | - | -$34.48 M(+37.1%) | -$109.47 M(+12.3%) |
| Mar 2022 | - | -$25.15 M(+5.6%) | -$97.48 M(+12.6%) |
| Dec 2021 | -$86.56 M(+3.0%) | -$23.81 M(-8.5%) | -$86.56 M(-6.8%) |
| Sept 2021 | - | -$26.03 M(+15.7%) | -$92.88 M(+7.6%) |
| June 2021 | - | -$22.49 M(+58.1%) | -$86.33 M(+6.5%) |
| Mar 2021 | - | -$14.23 M(-52.8%) | -$81.04 M(-3.6%) |
| Dec 2020 | -$84.04 M(+11.4%) | -$30.13 M(+54.6%) | -$84.04 M(+14.1%) |
| Sept 2020 | - | -$19.49 M(+13.3%) | -$73.64 M(-0.4%) |
| June 2020 | - | -$17.20 M(-0.2%) | -$73.94 M(-3.0%) |
| Mar 2020 | - | -$17.23 M(-12.7%) | -$76.20 M(+1.0%) |
| Dec 2019 | -$75.44 M | -$19.73 M(-0.3%) | -$75.44 M(+2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$19.79 M(+1.7%) | -$73.74 M(+5.8%) |
| June 2019 | - | -$19.45 M(+18.2%) | -$69.69 M(+8.4%) |
| Mar 2019 | - | -$16.46 M(-8.7%) | -$64.28 M(+3.2%) |
| Dec 2018 | -$62.28 M(+15.3%) | -$18.03 M(+14.6%) | -$62.28 M(+4.6%) |
| Sept 2018 | - | -$15.74 M(+12.0%) | -$59.55 M(+3.3%) |
| June 2018 | - | -$14.05 M(-2.9%) | -$57.64 M(+1.2%) |
| Mar 2018 | - | -$14.46 M(-5.5%) | -$56.96 M(+5.5%) |
| Dec 2017 | -$54.01 M(+13.1%) | -$15.30 M(+10.7%) | -$54.01 M(+8.7%) |
| Sept 2017 | - | -$13.82 M(+3.4%) | -$49.67 M(-0.7%) |
| June 2017 | - | -$13.37 M(+16.1%) | -$50.02 M(+2.8%) |
| Mar 2017 | - | -$11.52 M(+5.0%) | -$48.67 M(+1.9%) |
| Dec 2016 | -$47.74 M(+60.1%) | -$10.96 M(-22.6%) | -$47.74 M(+0.6%) |
| Sept 2016 | - | -$14.17 M(+17.9%) | -$47.47 M(+13.7%) |
| June 2016 | - | -$12.02 M(+13.5%) | -$41.76 M(+16.5%) |
| Mar 2016 | - | -$10.59 M(-0.9%) | -$35.84 M(+20.2%) |
| Dec 2015 | -$29.82 M(+122.0%) | -$10.69 M(+26.3%) | -$29.82 M(+55.9%) |
| Sept 2015 | - | -$8.46 M(+38.8%) | -$19.13 M(+79.4%) |
| June 2015 | - | -$6.10 M(+33.5%) | -$10.66 M(+133.5%) |
| Mar 2015 | - | -$4.57 M | -$4.57 M |
| Dec 2014 | -$13.43 M | - | - |
FAQ
- What is Syros Pharmaceuticals annual net profit?
- What is the all time high annual net income for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals annual net income year-on-year change?
- What is Syros Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals quarterly net income year-on-year change?
- What is Syros Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals TTM net income year-on-year change?
What is Syros Pharmaceuticals annual net profit?
The current annual net income of SYRS is -$164.57 M
What is the all time high annual net income for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high annual net profit is -$13.43 M
What is Syros Pharmaceuticals annual net income year-on-year change?
Over the past year, SYRS annual net profit has changed by -$69.92 M (-73.87%)
What is Syros Pharmaceuticals quarterly net profit?
The current quarterly net income of SYRS is -$6.40 M
What is the all time high quarterly net income for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high quarterly net profit is -$3.71 M
What is Syros Pharmaceuticals quarterly net income year-on-year change?
Over the past year, SYRS quarterly net profit has changed by +$33.75 M (+84.07%)
What is Syros Pharmaceuticals TTM net profit?
The current TTM net income of SYRS is -$97.81 M
What is the all time high TTM net income for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high TTM net profit is -$4.57 M
What is Syros Pharmaceuticals TTM net income year-on-year change?
Over the past year, SYRS TTM net profit has changed by +$7.15 M (+6.81%)